Encompass Health Corp/ US29261A1007 /
| 2024-04-26 9:59:33 PM | Chg. - | Volume | Bid3:22:34 PM | Ask3:22:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 82.55USD | - | 41,374 Turnover: 1.61 mill. |
-Bid Size: - | -Ask Size: - | 8.26 bill.USD | 0.73% | 23.50 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,959.3000 | 2,206.6000 | 2,601.6000 | 2,939.2000 | 3,301 | ||||||
| Intangible Assets | 476.3000 | 431.3000 | 417.5000 | 282.3000 | 278.2000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 5,324.9000 | 5,497.3000 | 5,943.5000 | 4,919.3000 | 5,260.6000 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 506.1000 | 572.8000 | 680.3000 | 536.8000 | 611.6000 | ||||||
| Cash and Cash Equivalents | 94.8000 | 224 | 54.8000 | 21.8000 | 69.1000 | ||||||
| Current Assets | 755.8000 | 948.6000 | 921.4000 | 717.2000 | 841.8000 | ||||||
| Total Assets | 6,080.7000 | 6,445.9000 | 6,864.9000 | 5,636.5000 | 6,102.4000 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 94.6000 | 115 | 137.6000 | 132.9000 | 170 | ||||||
| Long-term debt | 3,023.3000 | 3,250.6000 | 3,243.9000 | 2,741.8000 | 2,687.8000 | ||||||
| Liabilities to Banks | 3,023.3000 | 3,250.6000 | 3,243.9000 | - | - | ||||||
| Provisions | - | 51.8000 | 86.7000 | - | - | ||||||
| Liabilities | 4,387.6000 | 4,475.9000 | 4,507.9000 | 3,810.2000 | 3,847.2000 | ||||||
| Share Capital | 1.1000 | 1.1000 | 1.1000 | 1.1000 | 1.2000 | ||||||
| Total Equity | 1,693.1000 | 1,970 | 2,357 | 1,826.3000 | 2,255.2000 | ||||||
| Minority Interests | 340.9000 | 382 | 445.7000 | 516 | 607.7000 | ||||||
| Total liabilities equity | 6,080.7000 | 6,445.9000 | 6,864.9000 | 5,636.5000 | 6,102.4000 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 4,605 | 4,644.4000 | 5,121.6000 | 4,348.6000 | 4,801.2000 | ||||||
| Depreciation (total) | 218.7000 | 243 | 256.6000 | 243.6000 | 273.9000 | ||||||
| Operating Result | - | - | - | - | - | ||||||
| Interest Income | 159.7000 | 184.2000 | 164.6000 | 175.7000 | 143.5000 | ||||||
| Income Before Taxes | 562.3000 | 472.6000 | 657.2000 | 450.8000 | 607.2000 | ||||||
| Income Taxes | 115.9000 | 103.8000 | 139.6000 | 100.1000 | 132.2000 | ||||||
| Minority Interests Profit | -87.1000 | -84.6000 | -105 | -94.9000 | -111 | ||||||
| Net Income | 358.7000 | 284.2000 | 412.2000 | 271 | 352 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 635.3000 | 704.7000 | 715.8000 | 705.8000 | 850.8000 | ||||||
| Cash Flow from Investing Activities | -657.4000 | -407.5000 | -666.3000 | -627 | -602.8000 | ||||||
| Cash Flow from Financing | 48.2000 | -145.9000 | -240.1000 | -145.7000 | -197.2000 | ||||||
| Decrease / Increase in Cash | 26.1000 | 151.3000 | -190.6000 | -66.9000 | 50.8000 | ||||||
| Employees | 31,570 | 43,178 | 43,400 | - | - | ||||||
